fda indications for semaglutide Early uptake of Wegovy pill semaglutide fda approved indications GLP-1

Weight Loss Potential: Based on separate clinical trials (they haven't been directly compared in the same study yet), Tirzepatide appears to produce somewhat greater weight loss on average compared to Wegovy

Narvin, J., Rojo-Lpez, M.I., Martinez-Santos, P., Rossell, J., Ruiz-Alcaraz, A.J., Alonso, N., Ramos-Molina, B., Mauricio, D., & Julve, J

Rather than taking a one-size-fits-all approach, a clinic like MTC can evaluate your medical history, discuss your wellness goals, and help determine if therapies like GLP-1 weight loss injections are a safe and appropriate fit for you

Semaglutide (Ozempic, Wegovy) is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide (Mounjaro, Zepbound) is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist

Go to Quince.com/willcole for 365-day returns, plus free shipping on your order